Intragastric amorphous calcium carbonate consumption triggered generation of in situ hydrogel piece for sustained drug release

Xiang Xu,Hao Liu,Jiaming Guo,Zhiyi Huo,Jia Liu,Zhenghong Wu,Xiaole Qi
DOI: https://doi.org/10.1016/j.ijpharm.2020.119880
IF: 6.51
2020-11-01
International Journal of Pharmaceutics
Abstract:<p>Sustained-release systems in solid forms are widely accepted except for those patients with dysphagia such as the elderly and infants. Herein, we have developed a sustained-release oral drug solution by dispersing polyaspartic acid stabilized amorphous calcium carbonate (ACC) nanoparticles (NPs) (&lt;100 nm) in drug-containing sodium alginate (SA) solution (2%). It can be supposed that ACC NPs would consume in the gastrointestinal tract acid environment and provide calcium ions as the crosslinker for SA polymer solution to gain <em>in situ</em> hydrogels. The pre-gel solution system appeared a distinct reversible shear-thin characteristic with high viscosity and stability during storage. Whereas, it can regain fine flowability for convenient oral administration after slightly shaking. In this study, ACC NPs consumption triggered solution-gel transition of this drug-containing pre-gel solution system was demonstrated in simulated gastric solution and <em>in vivo</em>, with the distinct sustained drug release profiles lasting for 10 h. In addition, pharmacokinetics studies in SD rats showed that the T<sub>max</sub> (up to 1.79 ± 0.24 h) and AUC<sub>0-12</sub> (46.37 ± 2.71 μg/mL·h) of ACC/SA <em>in situ</em> hydrogels treated group were significantly higher (<em>p</em> &lt; 0.05) than that of free drug solution. Overall, these results highlighted a novel promising platform for oral administration of drugs, reduced dosing frequency, and high potential compliance for patients with dysphagia.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?